Cathie Wood acquired 6.27 Million Twist Bioscience shares worth $226 Million. That's 1.65% of their equity portfolio (21st largest holding). The investor owns 11.21% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares seven more times and sold shares on three occasions. The investor's estimated purchase price is $434 Million, resulting in a loss of 48%.